ADENTRA (ADEN) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
12 Mar, 2026Executive summary
Sales for 2025 reached $2.25 billion, up 3% year-over-year, driven by the Woolf acquisition and improved pricing, despite lower organic volumes and FX headwinds.
Adjusted EBITDA for 2025 was $187.9 million, up 2% year-over-year, with a margin of 8.4%.
Strong operating cash flow of over $160 million enabled share repurchases, dividend increases, and capital returns to shareholders.
The company maintained operational excellence and margin discipline despite a muted construction environment.
Integration of Woolf Distributing expanded U.S. Midwest presence and specialty product exposure.
Financial highlights
Q4 2025 sales were $517.5 million, down 2.5% year-over-year, mainly due to lower volumes, partially offset by improved pricing.
Q4 gross margin was $114.4 million (22.1% of sales), up from 21.7% in Q4 2024, aided by procurement discipline and vendor rebate true-ups.
Adjusted EBITDA for Q4 was $43.7 million, up 3.7% year-over-year.
Q4 net income was $32.1 million ($1.32 per share), up from $8.4 million in the prior year quarter, driven by lower finance expense and deferred tax asset recognition.
Adjusted EPS for Q4 was $0.67, up from $0.51 year-over-year.
Outlook and guidance
Entering 2026 with measured caution due to elevated U.S. mortgage rates, limited housing inventory, and macroeconomic/geopolitical uncertainty.
Sales in the first two months of 2026 were down approximately 2% year-over-year, mainly due to lower volumes and weather impacts.
Long-term fundamentals remain positive, supported by housing undersupply, demographics, and aging housing stock.
Effective tax rate expected to normalize around 27% in 2026, barring one-time items.
CapEx for 2026 projected in the $10–12 million range, focused on maintenance.
Latest events from ADENTRA
- Sustained growth, strategic acquisitions, and operational excellence drive long-term value creation.ADEN
Investor presentation16 Mar 2026 - Q3 sales rose 4.1% to $592.1M, with strong margins, cash flow, and higher dividends.ADEN
Q3 202516 Mar 2026 - Strong growth, disciplined M&A, and operational excellence drive double-digit returns.ADEN
Investor presentation16 Mar 2026 - Net income and margins surged in Q2 2024 despite lower sales, driven by cost discipline and M&A.ADEN
Q2 20241 Feb 2026 - Sales up 1.8% to $568.8M, net income up 28.7%, gross margin 21.3%, and dividend increased.ADEN
Q3 202414 Jan 2026 - 2024 sales fell 2.5% but net income rose 28.9% as margins and US reach improved.ADEN
Q4 202426 Dec 2025 - Sales up 1.4% on acquisition, but organic sales and profit fell amid macro headwinds.ADEN
Q1 202524 Nov 2025 - Q2 sales up 8.7% to $597.1M, with margin growth and strong cash flow despite trade risks.ADEN
Q2 202523 Nov 2025 - Sustained growth, strong M&A, and operational excellence drive double-digit shareholder returns.ADEN
Investor Presentation7 Aug 2025